FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * Hait William 2. Date of Event Requiring Statement (MM/DD/YYYY)
1/3/2022 

3. Issuer Name and Ticker or Trading Symbol JOHNSON & JOHNSON [JNJ]
(Last)       (First)       (Middle)
ONE JOHNSON & JOHNSON PLAZA
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
See Remarks /
(Street)
NEW BRUNSWICK, NJ 08933      
(City)             (State)             (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)
 

6. Individual or Joint/Group Filing(Check Applicable Line)_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock  223158.0000  D   

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Options (Right to Buy) (1) 2/11/2017  2/9/2024  Common Stock  59397.0000  $90.4400  D   
Employee Stock Options (Right to Buy) (1) 2/10/2018  2/9/2025  Common Stock  51484.0000  $100.0600  D   
Employee Stock Options (Right to Buy) (1) 2/9/2019  2/8/2026  Common Stock  54923.0000  $101.8700  D   
Employee Stock Options (Right to Buy) (1) 2/13/2020  2/13/2027  Common Stock  41097.0000  $115.6700  D   
Employee Stock Options (Right to Buy) (1) 2/12/2021  2/11/2028  Common Stock  37289.0000  $129.5100  D   
Employee Stock Options (Right to Buy) (1) 2/11/2022  2/11/2029  Common Stock  37911.0000  $131.9400  D   
Employee Stock Options (Right to Buy) (1) 2/10/2023  2/10/2030  Common Stock  49315.0000  $151.4100  D   
Employee Stock Options (Right to Buy) (1) 2/8/2024  2/8/2031  Common Stock  33593.0000  $164.6200  D   
Restricted Share Units (2) 2/8/2024   (2) Common Stock  3059.0000   (2) D   
Restricted Share Units (2) 2/10/2023   (2) Common Stock  3856.0000   (2) D   
Restricted Share Units (2) 2/11/2022   (2) Common Stock  7790.0000   (2) D   

Explanation of Responses:
(1)  Vested and exercisable on the third anniversary of the date of the grant.
(2)  Each Restricted Share Unit represents a contingent right to receive one share of Company Common Stock and vests on the third anniversary of the date of grant.

Remarks:
haitpoa1.txt

Title: Executive Vice President, Chief External Innovation, Medical Safety and Global Public Health Officer

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Hait William
ONE JOHNSON & JOHNSON PLAZA
NEW BRUNSWICK, NJ 08933


See Remarks

Signatures
Raavi Deol, as attorney-in-fact for William Hait 1/13/2022
**Signature of Reporting Person Date
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Johnson and Johnson Charts.